AIONCO

Serial Number 97646050
602

Registration Progress

Application Filed
Oct 24, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

AIONCO

Basic Information

Serial Number
97646050
Filing Date
October 24, 2022
Abandonment Date
February 12, 2024
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Mar 15, 2024
Classes
044

Rights Holder

Avellino Lab USA, Inc.

03
Address
1505 Adams Drive, Suite B2
Menlo Park, CA 94025

Ownership History

Avellino Lab USA, Inc.

Original Applicant
03
Menlo Park, CA

Legal Representation

Attorney
Andrew J. Gray IV

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

11 events
Date Code Type Description Documents
Mar 15, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Mar 15, 2024 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Nov 10, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Nov 10, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Aug 11, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 11, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 11, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 9, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 8, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 27, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Providing medical diagnostic and treatment services, namely, tumor detection in the form of a liquid biopsy; medical diagnostic and treatment services in the nature of tumor analysis, diagnosis, and identification in the form of sequenced tissue identification, and tumor medical treatment therapy in the form of identification of appropriate combination of mutations for targeted cancers and identification of appropriate treatments targeted for those combination of mutations via modified T-Cells in the form of other treatments to inhibit expressions of those combination of mutations and to modify one or more of the mutations in the combination
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a circle which is circumscribed appearing next to the word "AIONCO" in a stylized font resembling a DNA sequence in orange and red color. Within the ring of the circle are other circles layered together with colors blue and teal. The background is transparent. White is not claimed as a color of the mark.
Color Claim
The color(s) blue, teal, orange and red is/are claimed as a feature of the mark.

Classification

International Classes
044